Jefferies Financial Group’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.3M Buy
+84,900
New +$1.05M 0.01% 854
2024
Q3
Sell
-33,177
Closed -$368K 1594
2024
Q2
$368K Buy
+33,177
New +$412K ﹤0.01% 1048
2023
Q1
Sell
-34,241
Closed -$479K 1783
2022
Q4
$479K Buy
+34,241
New +$934K ﹤0.01% 1073

Other funds holding IMUX

Jefferies Financial Group's IMUX Position: Q2 2026 in Review

Jefferies Financial Group opened a new position in Immunic (IMUX) in Q2 2026: 84,900 shares worth $1.3M. The stake represents 0.01% of the portfolio and ranks #854 among its holdings. This is a return to the name: Jefferies Financial Group previously reported a position in IMUX as recently as Q2 2024.

Jefferies Financial Group first reported a position in IMUX in Q4 2022 and has held it in 3 quarters since. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • Jefferies Financial Group held 84,900 shares of Immunic worth $1.3M as of Q2 2026.
  • Immunic was a new Jefferies Financial Group position in Q2 2026.
  • Immunic made up 0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #854 holding.
  • Jefferies Financial Group first reported a position in Immunic in Q4 2022 and has held it in 3 quarters since.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.